Category: Press Release

THERANOS REACHES SETTLEMENT WITH WALGREENS

Theranos announced today that it has entered a confidential settlement agreement with Walgreen Co. and Walgreens Boots Alliance, Inc., resolving all claims among those parties.

August 1, 2017

THERANOS NAMES FORMER ABBOTT DIAGNOSTICS EXECUTIVE CASS GRANDONE AS HEAD OF PRODUCT DEVELOPMENT

Theranos today announced that a key role has been filled on the company’s executive team, with the arrival of Cass Grandone as Senior Vice President of Product Development.

May 17, 2017

THERANOS FINALIZES SHAREHOLDER RECAPITALIZATION

Theranos finalizes shareholder recapitalization; Transaction unifies major investors around forward-looking business plans.

May 16, 2017

THERANOS REACHES SETTLEMENT WITH PARTNER FUND MANAGEMENT

Theranos reaches settlement with Partner Fund Management. Tender offer recapitalizing major shareholders scheduled to close May 15.

May 1, 2017

Theranos, Arizona Attorney General Reach Agreement on Full Restitution to State Consumers

Company to reimburse more than those whose tests were voided and corrected; Resolution ends all existing and potential claims against Theranos in the state.

April 18, 2017

Theranos Reaches Resolution with Centers For Medicare & Medicaid Services

CMS withdraws revocation of CLIA certificates and reduces civil monetary penalty; Theranos withdraws appeal, completing exit from the clinical lab business.

April 17, 2017

Theranos Announces Engineering Experts Join Company’s New Technology Advisory Board

Theranos, Inc. announced that engineering and biomedical device design experts have joined the company’s newly created Technology Advisory Board (TAB).

January 17, 2017

Theranos Enhances Executive Ranks

Theranos names operations chief, communications leader, general counsel to executive team; adds molecular pathologist to scientific board.

December 12, 2016

Theranos Adds Silicon Valley Executive to Board of Directors

Riley Bechtel Retires from Board; Company to Retire Board of Counselors Structure in Consolidation of Advisory Framework

December 1, 2016

COMPANY STATEMENT REGARDING INVESTOR LAWSUIT

Theranos responds to recent report of a lawsuit filed by an investor.

October 11, 2016